Immutrin
Biotechnology Research
Cambridge, Cambridgeshire, United Kingdom
6 employees
- Employees
- 6
- Contacts
- 2
- Emails
- 2
Immutrin Overview
- Headquarters
- Cambridge, Cambridgeshire, United Kingdom
- Industry
- Biotechnology Research
- Employees
- 6
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About Immutrin
Amyloidosis is a group of rare but very serious, usually fatal diseases caused by the aggregation of body’s own proteins to form amyloid deposits in vital organs. Immutrin is a Cambridge-based biotech company that is developing the next generation antibody therapies for systemic and local amyloidosis.
Immutrin Contact Details
- People in AeroLeads
- 4
- With contact data
- 2
- Email contacts
- 2
- 50.0% coverage
Immutrin Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Jack Wade, Ph.d | United Kingdom |
Email
|
|
| Michael Anstey | Partner at Cambridge Innovation Capital |
View
|
|
| Mihriban Tuna | Chief Executive Officer at Immutrin | United Kingdom |
Email
|
| Simon Coulthard | Experienced CFO - Saas - Start |
View
|
Employees by Management Level
Executive
2 profiles
Individual contributor
1 profile
Compare Similar Companies to Immutrin
T-Therapeutics Ltd
Biotechnology Research
Epitopea
Biotechnology
Cambridge Innovation Capital
Venture Capital And Private Equity Principals
TRIMTECH Therapeutics Limited
Biotechnology Research
Clock.Bio
Biotechnology Research
OutSee
Biotechnology Research
Avatrial
Biotechnology Research
MyImmune
Biotechnology Research
Awen Oncology
Biotechnology Research
Healthspan Biotics
Biotechnology Research